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Items for this week’s Epi Update include: 
 Additional potential cases of severe lung disease associated with vaping reported   
 Updated influenza vaccine recommendations for 2019-2020 season 
 Changes proposed to hepatitis C screening guidance for adults 
 Take-home lead a problem for Iowa toddlers 
 In the news: Measles - Four European nations lose eradication status 
 In the news: Should grandparents get new vaccinations? 
 In the news: Whatever happened to... The kids whose lead levels were off the 
charts? 
 Infographic: If you work around lead, don’t take it home!  
 Meeting announcements and training opportunities 
 
Additional potential cases of severe lung disease associated with vaping reported   
Seven potential cases of severe lung disease associated with vaping have been reported in 
Iowa. The potential cases are in young to middle-age adults. At least five of the seven potential 
cases reported vaping THC. Cases are being reported across the U.S. A variety of vaping 
products associated with the illnesses have been reported across states, but THC has been 
commonly associated with these illnesses.  
 
Youth should be discouraged from using vaping and e-cigarette products of any kind as the 
long-term health impacts for youth using these products are unknown. Patients with a history 
of vaping who are experiencing breathing problems should seek medical care. Health care 
providers should ask patients with respiratory illness about the use of vaping and e-cigarette 
products. Health care providers are asked to report severe respiratory illness in patients with a 
history of vaping or e-cigarette use to the Iowa Department of Public Health (1-800-362-2736). 
 
For additional information, visit https://idph.iowa.gov/ehi/lung-disease-vaping. 
 
Updated influenza vaccine recommendations for 2019-2020 season 
Routine annual influenza vaccination continues to be recommended for all persons 6 months 
and older who do not have a contraindication. There are two primary updates to this year’s 
influenza vaccine recommendations: 
 The age indication for Afluria Quadrivalent has been expanded from > 5 years to > 6 
months. The dose volume for children 6 through 35 months of age is 0.25mL and the 
dose volume for all persons >36 months of age is 0.5mL.  
 The dose volume for Fluzone Quadrivalent for children aged 6 through 35 months, 
which was previously 0.25mL, is now either 0.25mL OR 0.5mL. No preference is 
expressed for either volume. The dose volume for all persons >36 months is 0.5mL.  
 
The influenza vaccine composition includes updates in influenza A (H1N1) pdm09 and 
influenza A(H3N2) components. 2019-2020 U.S. trivalent vaccines contain an 
A/Brisbane/02/2018 (H1N1) pdm09-like virus, an A/Kansas/14/2017 (H3N2)-like virus, and a 
B/Colorado/06/2017-like virus (Victoria lineage). Quadrivalent vaccines contain these viruses 
and an additional influenza B vaccine virus, a B/Phuket/3073/2013-like virus (Yamagata 
lineage).  
 
For more information about the vaccine recommendations for the 2019-2020 season, visit 
www.cdc.gov/mmwr/volumes/68/rr/pdfs/rr6803-h.pdf?deliveryName=USCDC_921-DM7382.  
 
For more resources from IDPH about influenza vaccination, including an influenza dosing 
algorithm for children, guidelines on influenza vaccination for persons who report allergy to 
eggs, and a list of available vaccine products for the upcoming season, visit 
idph.iowa.gov/immtb/immunization/vaccine.  
 
Changes proposed to hepatitis C screening guidance for adults 
The U.S. Preventive Services Task Force (USPSTF) has drafted a revised Recommendation 
Statement for hepatitis C screening. The revised statement recommends that all adults ages 
18 to 79 should receive a hepatitis C screening at least once in their lifetime. This is an update 
from the previous recommendation, which stated that baby boomers (persons born between 
1945 and 1965) should be screened. In addition, pregnant adults should also be screened.  
 
The most important risk factor for HCV infection is past or current injection drug use. Recent 
increases in HCV incidence in the U.S. have predominantly been among young persons who 
inject drugs (PWID). Approximately one-third of PWID in the U.S. ages 18 to 30 have HCV, 
and 70 to 90% of older PWID are infected. Clinicians may consider screening adolescents 
younger than age 18 and adults older than age 79 who are at high risk. Screening for pregnant 
women is recommended because HCV prevalence doubled in U.S. women ages 15 to 44 from 
2006 to 2014. From 2011 to 2014, 0.73% of pregnant women tested had HCV, with a 68% 
increase in the proportion of infants born to mothers with HCV. 
 
In an effort to maintain a high level of transparency in the methods, the USPSTF opens the 
draft Recommendation Statements to a public comment period before they publish the final 
version. The comment period is open until September 23.  
 




Take-home lead a problem for Iowa toddlers 
IDPH has identified a number of cases of child lead poisoning linked to a parent’s lead 
exposure at work, or “take-home” lead. Lead dust from the workplace is easily transported on 
skin or clothing and transferred to a toddler’s hands or mouth where it can be ingested. Lead 
dust can also be inhaled from close contact with the worker’s clothes as a child snuggles.  
 
Medical providers should consider take-home lead as a possible source of exposure and 
provide guidance to families with young children. Infants and toddlers with the possibility of 
take-home lead exposure may benefit from additional lead testing to screen for exposure, in 
addition to routine testing at 12 and 24 months of age. 
 
For more information, visit idph.iowa.gov/Environmental-Health-Services/Occupational-Health-
and-Safety-Surveillance/Adult-Blood-Lead-Epidemiology.  
 
In the news: Measles - Four European nations lose eradication status 
www.bbc.com/news/health-49507253  
 








Infographic: If you work around lead, don’t take it home! 
 
 
To view in full size, visit www.osha.gov/Publications/OSHA3680.pdf.  
 
Meeting announcements and training opportunities 
IDPH and SHL will host an influenza webinar for the 2019-20 influenza season on Friday, 
September 13 at 10:30 AM. Topics covered include Iowa influenza surveillance data, outbreak 
management, influenza testing, vaccine recommendations and antiviral prophylaxis/treatment 
guidance. Target audiences include healthcare providers (hospital, clinic and long-term care), 
infection preventionists, laboratory staff, public health professionals and school health staff. 
To register, visit zoom.us/webinar/register/WN_MbuH79eMTaSTcbnmWU9abw.  
 
Have a healthy and happy week! 
Center for Acute Disease Epidemiology 
Iowa Department of Public Health 
800-362-2736 
